Article Excerpt: The commissioner of the United States Food and Drug Administration (FDA), Scott Gottlieb, says that addressing the opioid epidemic requires a bolder plan of action, and that the agency will require drug companies to initiate studies on whether opioids are effective treatment for chronic pain. Depending on the results of those studies, the FDA could change labeling requirements and even restrict the use of some prescription opioids that have long been used to treat prolonged pain conditions.
Full Article: https://tinyurl.com/y2drlt32
Article Source: Fortune